Ruane Cunniff Goldfarb Inc Lowers stake in DENTSPLY International (XRAY)

DENTSPLY International (XRAY) : Ruane Cunniff Goldfarb Inc reduced its stake in DENTSPLY International by 2.85% during the most recent quarter end. The investment management company now holds a total of 4,705,249 shares of DENTSPLY International which is valued at $295,348,480 after selling 138,075 shares in DENTSPLY International , the firm said in a disclosure report filed with the SEC on Jul 15, 2016.DENTSPLY International makes up approximately 2.73% of Ruane Cunniff Goldfarb Inc’s portfolio.

Other Hedge Funds, Including , Piershale Financial Group added XRAY to its portfolio by purchasing 610 company shares during the most recent quarter which is valued at $38,290. DENTSPLY International makes up approx 0.03% of Piershale Financial Group’s portfolio.First Manhattan Co boosted its stake in XRAY in the latest quarter, The investment management firm added 530 additional shares and now holds a total of 10,308 shares of DENTSPLY International which is valued at $647,033.Foundry Partners reduced its stake in XRAY by selling 58,029 shares or 55.37% in the most recent quarter. The Hedge Fund company now holds 46,777 shares of XRAY which is valued at $2,946,015. DENTSPLY International makes up approx 0.28% of Foundry Partners’s portfolio. Washington Trust Bank added XRAY to its portfolio by purchasing 68 company shares during the most recent quarter which is valued at $4,311.

DENTSPLY International closed down -0.19 points or -0.30% at $62.77 with 9,45,627 shares getting traded on Monday. Post opening the session at $63.02, the shares hit an intraday low of $62.39 and an intraday high of $63.22 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, DENTSPLY International reported $0.69 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on May 6, 2016. Analyst had a consensus of $0.62. The company had revenue of $772.60 million for the quarter, compared to analysts expectations of $778.36 million. The company’s revenue was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 EPS.

Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Initiated by Piper Jaffray to “Overweight” on Jun 13, 2016. Company shares were Reiterated by Barrington Research on May 13, 2016 to “Outperform”, Firm has raised the Price Target to $ 68 from a previous price target of $62 .

DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

DENTSPLY International - Is it time to Sell?

Top Brokerage Firms are advising their investors on DENTSPLY International. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.